Clinical Trial Search Results

138 studies were found about miconazole
Filter Results: All Studies Studies seeking new volunteers Studies with results

Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients

Condition: HIV Infections

NCT ID: NCT00390780

Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs

Condition: HIV Infections; Histoplasmosis

NCT ID: NCT00006316

A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS

Condition: Candidiasis, Oral; HIV Infections

NCT ID: NCT00002282

Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)

Condition: Candidiasis; Mycoses; HIV Infections

NCT ID: NCT00000676

DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate

Condition: HIV

NCT ID: NCT01731574

Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis

Condition: Meningitis, Cryptococcal; HIV Infections

NCT ID: NCT00012467

Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy

Condition: Candidiasis; Mycoses; HIV Infections

NCT ID: NCT00002038

TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.

Condition: HIV; AIDS; Fungal Infection

NCT ID: NCT00740389

The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection

Condition: Candidiasis, Oral; Eating Disorders; HIV Infections; Speech Disorders

NCT ID: NCT00001448

SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy

Condition: Meningitis, Cryptococcal; HIV Infections

NCT ID: NCT00000677

Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women

Condition: Trichomoniasis; Candidiasis; Bacterial Vaginosis

NCT ID: NCT01230814

A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis

Condition: HIV Infections; Histoplasmosis; Blastomycosis

NCT ID: NCT00002159

A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00000991

Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis

Condition: Acquired Immunodeficiency Syndrome; Aspergillosis; HIV Infections; Immunologic Deficiency Syndromes; Neutropenia

NCT ID: NCT00001646

Study of Itraconazole in Patients With Advanced HIV Infection

Condition: HIV Infections

NCT ID: NCT00002370

The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis

Condition: Meningitis, Cryptococcal; HIV Infections

NCT ID: NCT00002316

A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00002340

Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients

Condition: Candidiasis, Oral; HIV Infections

NCT ID: NCT00002446

A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush

Condition: Candidiasis, Oral; HIV Infections

NCT ID: NCT00000951

A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients

Condition: Candidiasis, Oral; HIV Infections

NCT ID: NCT00002399

Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment

Condition: Candidiasis, Oral; HIV Infections

NCT ID: NCT00002394

A Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in Patients With AIDS

Condition: HIV Infections; Histoplasmosis

NCT ID: NCT00000992

A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS

Condition: HIV Infections; Histoplasmosis

NCT ID: NCT00000975

A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women

Condition: Candidiasis; Candidiasis, Esophageal; HIV Infections

NCT ID: NCT00000744

A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical Pharmacokinetics of Methadone

Condition: Candidiasis; HIV Infections

NCT ID: NCT00000788

An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00001990

Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome

Condition: HIV Infections; Histoplasmosis

NCT ID: NCT00000627

Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder

Condition: HIV Associated Neurocognitive Disorder

NCT ID: NCT01354314

Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole

Condition: Candidiasis, Oral; HIV Infections

NCT ID: NCT00005920

A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis

Condition: Candidiasis, Esophageal; HIV Infections

NCT ID: NCT00005921

Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS

Condition: Meningitis, Cryptococcal; HIV Infections

NCT ID: NCT00001017

Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00000773

A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00000802

A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00000655

A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00001991

Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load

Condition: HIV Infections

NCT ID: NCT00959413

Thalidomide to Treat Oral Lesions in HIV-Infected Patients

Condition: Acquired Immunodeficiency Syndrome; Burning Mouth Syndrome; HIV Infection

NCT ID: NCT00001524

Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis

Condition: Cryptococcal Meningitis; HIV Infections

NCT ID: NCT00976040

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer

Condition: Accelerated Phase Chronic Myelogenous Leukemia; Acute Undifferentiated Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Diffuse Small Cleaved Cell Lymphoma; AIDS-related Immunoblastic Large Cell Lymphoma; AIDS-related Lymphoblastic Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Primary CNS Lymphoma; AIDS-related Small Noncleaved Cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Blastic Phase Chronic Myelogenous Leukemia; Burkitt Lymphoma; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Grade III Lymphomatoid Granulomatosis; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Eosinophilic Leukemia; Chronic Myelomonocytic Leukemia; Chronic Neutrophilic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Essential Thrombocythemia; Extramedullary Plasmacytoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; HIV Infection; HIV-associated Hodgkin Lymphoma; Intraocular Lymphoma; Isolated Plasmacytoma of Bone; Juvenile Myelomonocytic Leukemia; Mast Cell Leukemia; Meningeal Chronic Myelogenous Leukemia; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Polycythemia Vera; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Primary Central Nervous System Lymphoma; Primary Myelofibrosis; Primary Systemic Amyloidosis; Progressive Hairy Cell Leukemia, Initial Treatment; Prolymphocytic Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Splenic Marginal Zone Lymphoma; Stage 0 Chronic Lymphocytic Leukemia; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Hodgkin Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Adult T-cell Leukemia/Lymphoma; Stage I Childhood Anaplastic Large Cell Lymphoma; Stage I Childhood Hodgkin Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Childhood Lymphoblastic Lymphoma; Stage I Childhood Small Noncleaved Cell Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Multiple Myeloma; Stage I Mycosis Fungoides/Sezary Syndrome; Stage I Small Lymphocytic Lymphoma; Stage II Adult Hodgkin Lymphoma; Stage II Adult T-cell Leukemia/Lymphoma; Stage II Childhood Anaplastic Large Cell Lymphoma; Stage II Childhood Hodgkin Lymphoma; Stage II Childhood Large Cell Lymphoma; Stage II Childhood Lymphoblastic Lymphoma; Stage II Childhood Small Noncleaved Cell Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Multiple Myeloma; Stage II Mycosis Fungoides/Sezary Syndrome; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Childhood Anaplastic Large Cell Lymphoma; Stage III Childhood Hodgkin Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Lymphoblastic Lymphoma; Stage III Childhood Small Noncleaved Cell Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Multiple Myeloma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Childhood Anaplastic Large Cell Lymphoma; Stage IV Childhood Hodgkin Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Lymphoblastic Lymphoma; Stage IV Childhood Small Noncleaved Cell Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; T-cell Large Granular Lymphocyte Leukemia; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific; Waldenstrom Macroglobulinemia

NCT ID: NCT00112593

A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease

Condition: HIV Infections

NCT ID: NCT00000880

Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection With the Objective to Induce a Strong Specific HIV Immune Response Able to Control Viral Replication Without Highly Active Anti-Retroviral Therapy (HAART)

Condition: HIV

NCT ID: NCT00979706

Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00620438

Interactions Between HIV and Malaria in African Children

Condition: Malaria; HIV Infections

NCT ID: NCT00527800

Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults

Condition: HIV Infections; Malaria

NCT ID: NCT00869700

An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.

Condition: Candidiasis, Oral; HIV Infections

NCT ID: NCT00002133

Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in Tanzania

Condition: Malaria, Falciparum; HIV Infections

NCT ID: NCT00885287

Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study

Condition: Visceral Leishmaniosis; HIV-infection/Aids

NCT ID: NCT01360762

Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants

Condition: Human Immunodeficiency Virus Type 1 (HIV-1); HIV Infections

NCT ID: NCT00833482

A Study of Nystatin in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002313

A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.

Condition: HIV Infections

NCT ID: NCT00002097

A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole

Condition: Candidiasis, Oral; HIV Infections

NCT ID: NCT00001065

A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii Pneumonia

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00000974

A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Children Who Cannot Take Trimethoprim-Sulfamethoxazole

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00001027

Discontinuation of Primary and Secondary Prophylaxis for Opportunistic Infections in HIV-infected Patients

Condition: HIV Infection

NCT ID: NCT01392430

A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole

Condition: Candidiasis, Oral; HIV Infections

NCT ID: NCT00002341

A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common

Condition: Mycoses; HIV Infections; Coccidioidomycosis

NCT ID: NCT00002325

A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients

Condition: Mycoses; Mycobacterium Avium-Intracellulare Infection; HIV Infections

NCT ID: NCT00002122

A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00001028

Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus

Condition: Dry Eye Syndromes; HIV Seropositivity

NCT ID: NCT00797030

A Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected Patients

Condition: HIV Infections; Histoplasmosis

NCT ID: NCT00002438

Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome

Condition: Meningitis, Cryptococcal; HIV Infections

NCT ID: NCT00002019

Safety of and Immune Response to Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults With Acute HIV Infection

Condition: HIV Infections

NCT ID: NCT00084149

Comparing the Safety and Efficacy of Topical Gentian Violet Versus Nystatin Oral Suspension for the Treatment of Oropharyngeal Candidiasis in HIV-Infected People in Countries Outside of the United States

Condition: HIV Infections

NCT ID: NCT01494129

Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome

Condition: Meningitis, Cryptococcal; HIV Infections

NCT ID: NCT00002074

Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome

Condition: Candidiasis, Oral; HIV Infections

NCT ID: NCT00002112

Pharmacokinetics of Nystatin LF I.V. in Patients With Acquired Immune Deficiency Syndrome-Related Complex (ARC)

Condition: HIV Infections

NCT ID: NCT00001998

Study of Total Body Irradiation in Combination With Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation Followed By Cyclosporine and Mycophenolate Mofetil in High Risk-Patients With Human Immunodeficiency Virus-1

Condition: HIV Infections

NCT ID: NCT00010348

Drug Interaction Study Between Antimalarial and Anti-HIV Medications

Condition: HIV Infections; Malaria

NCT ID: NCT00266058

Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adults

Condition: Malaria; HIV

NCT ID: NCT00790881

High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals

Condition: Cryptococcal Meningitis; HIV Infections

NCT ID: NCT00885703

Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir

Condition: HIV Infections

NCT ID: NCT00619944

A Study of Two Forms of Pentamidine in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00002292

A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS

Condition: Meningitis, Cryptococcal; HIV Infections

NCT ID: NCT00002294

Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis

Condition: HIV-1 Infection

NCT ID: NCT01427738

Aerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia: A Pilot Study Assessing the Effectiveness of Aerosolized Pentamidine as Treatment of Subclinical Pneumocystis Infection in Patients With No Clinical Symptoms

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00000707

Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa

Condition: Cryptococcal Meningitis; HIV Infections

NCT ID: NCT00830856

Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy

Condition: HIV Infection; Malaria

NCT ID: NCT01728961

A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia.

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00002102

A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00001003

A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protection for European Adult Patients (>= 13 Years Old) With Pneumocystis Carinii Pneumonia

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00002103

A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems

Condition: Candidiasis, Esophageal; HIV Infections

NCT ID: NCT00002304

A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis

Condition: Meningitis, Cryptococcal; HIV Infections

NCT ID: NCT00002305

A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B

Condition: Meningitis, Cryptococcal; HIV Infections

NCT ID: NCT00002306

Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis

Condition: Meningitis, Cryptococcal; HIV Infections

NCT ID: NCT00000708

Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis

Condition: Meningitis; HIV Infections

NCT ID: NCT00002010

Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00001013

A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.

Condition: Meningitis, Cryptococcal; HIV Infections

NCT ID: NCT00002113

An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved Therapies

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00000714

Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00001014

A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia in AIDS

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00000715

A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00001016

A Study of Trimetrexate Plus Leucovorin in Children With Pneumocystis Carinii Pneumonia

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00002317

Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00002120

Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00000722

A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00000724

Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites

Condition: Bacterial Infections; Mycoses; HIV Infections

NCT ID: NCT00000826

A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00000727

Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00000730

An Open Label Study to Evaluate the Long-Term Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00002030

Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.

Condition: Candidiasis, Esophageal; HIV Infections

NCT ID: NCT00002132

A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP)

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00002434

A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis

Condition: Meningitis, Cryptococcal; HIV Infections

NCT ID: NCT00000639

A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems

Condition: Candidiasis, Esophageal; HIV Infections

NCT ID: NCT00002339

Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis

Condition: Meningitis, Cryptococcal; HIV Infections

NCT ID: NCT00002040

Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients

Condition: Candidiasis, Esophageal; HIV Infections

NCT ID: NCT00002041

A Double-Blind Placebo-Controlled Group Comparative Study To Evaluate the Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With AIDS Post First Episode PCP

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00002053

A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 Mg Versus 120 Mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00002054

A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients With Multiple Episodes of PCP

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00002055

A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral / Oral Trimethoprim - Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia in AIDS

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00002056

Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC

Condition: Candidiasis, Oral; HIV Infections

NCT ID: NCT00002057

A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis

Condition: Meningitis, Cryptococcal; HIV Infections

NCT ID: NCT00002068

Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis

Condition: Meningitis, Cryptococcal; HIV Infections

NCT ID: NCT00002075

Dexamethasone in Cryptococcal Meningitis

Condition: Meningitis, Cryptococcal; HIV Infections

NCT ID: NCT00000776

Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis

Condition: Meningitis, Cryptococcal; HIV Infections

NCT ID: NCT00002076

An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis

Condition: Meningitis, Cryptococcal; HIV Infections

NCT ID: NCT00002077

The Safety and Effectiveness of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Who Have Had PCP Before

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00002291

Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations

Condition: HIV Infections; Malaria

NCT ID: NCT00697892

A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes

Condition: Candidiasis, Oral; HIV Infections

NCT ID: NCT00002293

A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00001996

A Study of Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Not Previously Treated for PCP

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00000998

Corticosteroids Therapy on the Development of Interstitial Fibrosis in Patients With HIV Infection and Mild Pneumocystis Jirovecii Pneumonia (PCP)

Condition: Pneumocystis Carinii Pneumonia

NCT ID: NCT00636935

Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir

Condition: HIV Infection; Fungal Infection

NCT ID: NCT00817765

Increasing HAART-Induced Immune Restoration With Cyclosporine

Condition: HIV Infections

NCT ID: NCT00031070

A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections

Condition: Mycoses; HIV Infections

NCT ID: NCT00002277

Operational Research for Cryptococcal Antigen Screening

Condition: Cryptococcal Meningitis; Cryptococcus Neoformans; Cryptococcosis

NCT ID: NCT01535469

Fluconazole Prophylaxis of Thrush in AIDS

Condition: Acquired Immunodeficiency Syndrome; Candidiasis; Oral Candidiasis

NCT ID: NCT00001542

A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease

Condition: Endothelial Dysfunction

NCT ID: NCT01578772

Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Burundi

Condition: Cryptococcal Meningitis

NCT ID: NCT01715922

Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma

Condition: Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; HIV-associated Hodgkin Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia

NCT ID: NCT01076543

Comparative Evaluation of the Safety and the Efficacy of 2 Antimalarials Depending on HIV Status

Condition: Plasmodium Falciparum Malaria

NCT ID: NCT00304980

Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma

Condition: Sarcoma

NCT ID: NCT00450320

Single Dose Versus Two Weeks Course of Fluconazole in the Treatment of Oropharyngeal Candidiasis in HIV Infected Individuals in Tanzania

Condition: Oropharyngeal Candidiasis

NCT ID: NCT00553137

Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis

Condition: Cryptococcal Meningitis

NCT ID: NCT00145249

Reducing Vaginal Infections in Women

Condition: Bacterial Diseases; Other Mycoses; Sexually Transmitted Infection

NCT ID: NCT00170430

Safety, Efficacy, and Pharmacokinetics of Amphotericin B Lipid Complex

Condition: Invasive Cryptococcosis

NCT ID: NCT01656382

Nevirapine Levels and Fluconazole

Condition: Nevirapine; Fluconazole; Adverse Event

NCT ID: NCT00309582

Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection

Condition: Cryptococcal Infection Disseminated

NCT ID: NCT01562132

Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma

Condition: Lymphoma

NCT ID: NCT00024128